{"title":"Dorsal Onlay Labial Mucosal Graft Urethroplasty in Female Urethral Stricture: Outcomes of Over 200 Cases from a Single Surgeon.","authors":"Ajit Kumar Jena, Rahul Jena, Manupirya Madhavan, Kumar Madhavan","doi":"10.1016/j.urology.2025.05.040","DOIUrl":null,"url":null,"abstract":"<p><strong>Ovjectives: </strong>To evaluate the outcomes of dorsal onlay labial mucosal graft urethroplasty in female urethral stricture (FUS), a condition that remains challenging and frequently underdiagnosed due to nonspecific symptoms and diagnostic limitations.</p><p><strong>Methods: </strong>A retrospective analysis of a prospectively maintained database was conducted, including 204 patients who underwent dorsal onlay labial mucosal graft urethroplasty for FUS between June 2013 and July 2024. Patients were included if they had symptomatic FUS confirmed by uroflowmetry, micturating cystourethrogram (MCU), or urethral calibration. Outcomes assessed included clinical success rates, recurrence, complications, and subjective improvement based on the Global Impression of Improvement (GII).</p><p><strong>Results: </strong>The mean operative time was 97.7 ± 13 minutes, with a median hospital stay of 2 days (range: 2-11). Perioperative complications were minimal, with six cases (2.94%) of Clavien-Dindo grade 2-3 complications and no significant donor-site morbidity. At a median follow-up of 29 months (range: 7-231), clinical success rates were 98.5%, 97.5%, and 93.5% at 1-3 months, 6 months, and 2 years, respectively. Recurrence was observed in 6.5% of patients at 2 years, with 4 requiring repeat urethroplasty. Symptom improvement was reported by 95% of patients at 1-3 months and 88.1% at 2 years.</p><p><strong>Conclusions: </strong>Dorsal onlay labial mucosal graft urethroplasty is a safe and effective treatment for FUS, with high success rates, minimal complications, and durable outcomes. This study, the largest single-surgeon series, highlights the utility of this approach as a reliable option for managing this underdiagnosed condition.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.urology.2025.05.040","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Ovjectives: To evaluate the outcomes of dorsal onlay labial mucosal graft urethroplasty in female urethral stricture (FUS), a condition that remains challenging and frequently underdiagnosed due to nonspecific symptoms and diagnostic limitations.
Methods: A retrospective analysis of a prospectively maintained database was conducted, including 204 patients who underwent dorsal onlay labial mucosal graft urethroplasty for FUS between June 2013 and July 2024. Patients were included if they had symptomatic FUS confirmed by uroflowmetry, micturating cystourethrogram (MCU), or urethral calibration. Outcomes assessed included clinical success rates, recurrence, complications, and subjective improvement based on the Global Impression of Improvement (GII).
Results: The mean operative time was 97.7 ± 13 minutes, with a median hospital stay of 2 days (range: 2-11). Perioperative complications were minimal, with six cases (2.94%) of Clavien-Dindo grade 2-3 complications and no significant donor-site morbidity. At a median follow-up of 29 months (range: 7-231), clinical success rates were 98.5%, 97.5%, and 93.5% at 1-3 months, 6 months, and 2 years, respectively. Recurrence was observed in 6.5% of patients at 2 years, with 4 requiring repeat urethroplasty. Symptom improvement was reported by 95% of patients at 1-3 months and 88.1% at 2 years.
Conclusions: Dorsal onlay labial mucosal graft urethroplasty is a safe and effective treatment for FUS, with high success rates, minimal complications, and durable outcomes. This study, the largest single-surgeon series, highlights the utility of this approach as a reliable option for managing this underdiagnosed condition.
期刊介绍:
Urology is a monthly, peer–reviewed journal primarily for urologists, residents, interns, nephrologists, and other specialists interested in urology
The mission of Urology®, the "Gold Journal," is to provide practical, timely, and relevant clinical and basic science information to physicians and researchers practicing the art of urology worldwide. Urology® publishes original articles relating to adult and pediatric clinical urology as well as to clinical and basic science research. Topics in Urology® include pediatrics, surgical oncology, radiology, pathology, erectile dysfunction, infertility, incontinence, transplantation, endourology, andrology, female urology, reconstructive surgery, and medical oncology, as well as relevant basic science issues. Special features include rapid communication of important timely issues, surgeon''s workshops, interesting case reports, surgical techniques, clinical and basic science review articles, guest editorials, letters to the editor, book reviews, and historical articles in urology.